Aether Biomachines

Aether Biomachines

Engineers enzymes for diverse chemical processes

About Aether Biomachines

Simplify's Rating
Why Aether Biomachines is rated
A
Rated A on Competitive Edge
Rated B on Growth Potential
Rated A+ on Differentiation

Industries

Data & Analytics

Biotechnology

Company Size

51-200

Company Stage

Series A

Total Funding

$49M

Headquarters

Menlo Park, California

Founded

2017

Overview

Aether Biomachines specializes in engineering enzymes for clients in various industries, helping them manufacture complex products at lower costs. The company uses proprietary hardware to conduct massively parallel experiments, allowing them to generate large data sets and discover novel biocatalysts. This unique capability enables Aether to design enzymes for a wide range of chemical processes within clients' timelines. Unlike competitors, Aether's approach involves mapping trillions of enzymes to create a searchable index, which enhances their efficiency and effectiveness. The company's goal is to lead advancements in biotechnology and trigger a new industrial revolution by providing high-value enzyme engineering services.

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased demand for sustainable manufacturing boosts Aether Bio's enzyme engineering services.
  • AI-driven drug discovery opens collaboration opportunities with pharmaceutical companies.
  • Synthetic biology market expansion offers significant growth potential for Aether Bio.

What critics are saying

  • Competition from Zymergen and Ginkgo Bioworks threatens Aether Bio's market position.
  • Rapid AI advancements could render Aether Bio's technology obsolete if not updated.
  • Regulatory challenges in biotechnology may impact Aether Bio's operations.

What makes Aether Biomachines unique

  • Aether Bio uses machine learning to repurpose enzymes for new compound creation.
  • Proprietary hardware allows massively parallelized experimentation, generating large datasets.
  • First company to search sequence space for novel biocatalysts, enhancing enzyme design.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$49M

Above

Industry Average

Funded Over

1 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Above Average

Industry standards

$15M
$8.2M
Discord
$15M
Canva
$30M
Kalshi
$49M
Aether Biomachines

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 3%

2 year growth

↑ 8%
Fashion Network
Dec 5th, 2023
Aether opens new store in SoHo, NYC

Known to display large "props" in-store, Aether has introduced 'Snoley', a 1973 Harley Davidson Aermacchi custom snow bike crafted by award-winning conceptual designer J.Ruiter.

Finsmes
Aug 16th, 2023
Aether Raises $49M In Series A Funding

Aether, a Menlo Park, CA-based nanoscale machinery company that can assemble new classes of molecules to create enhanced products, raised $49M in Series A funding.The round was led by Jay Zaveri at Natural Capital and Trevor Zimmerman at Unless.The company intends to use the funds to scale its platform and grow its engineering, machine learning, and hardware teams.Led by CEO Pavle Jeremic, Aether provides a molecular assembler platform that can extract lithium from previously-inaccessible reserves and create enhanced products across industries including automotive, healthcare, home electronics, and more. The platform combines high-throughput robotics, machine learning, and synthetic biology to map millions of enzyme-reaction combinations. By generating high amounts of experimental data, the platform is able to engineer entirely new classes of nanoscale machines using protein building blocks called molecular assemblers. These molecular assemblers contain the power and sophistication of gigantic chemical factories, but on the scale of nanometers. Aether will initially focus its lithium extraction efforts in the southern, middle portions of the United States, including Oklahoma and Arkansas, where subterranean lithium exists in sizable amounts but at lower concentrations. Texas and Oklahoma will also be key areas of focus given the company’s ability to extract lithium from oil and gas wastewater byproducts, as well as capped oil wells. FinSMEs16/08/2023

Fast Company
Aug 16th, 2023
This startup developed a cheaper, greener way to extract lithium for EV batteries

The company, Aether, announced today that it raised $49 million in a Series A round led by Natural Capital and Unless.

Business Wire
Apr 12th, 2022
Aetherbio partners with Allonnia

“Aether is proud to partner with Allonnia to develop these novel, natural solutions and improve the lives of everyone, everywhere.”

Business Wire
Dec 1st, 2021
Aetherbio hired Austin Che as Board of Directors on Dec 1st 21'.

Aether Biomachines, a leading enzyme engineering company building a future of abundance, today announced the appointment of Austin Che to its Board of Directors.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Aether Biomachines right now.

Find jobs on Simplify and start your career today

đź’ˇ
We update Aether Biomachines's jobs every few hours, so check again soon! Browse all jobs →